PlainRecalls
FDA Devices Moderate Class II Ongoing

therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711

Reported: September 7, 2022 Initiated: July 20, 2022 #Z-1651-2022

Product Description

therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711

Reason for Recall

Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects

Details

Recalling Firm
Qiagen Sciences LLC
Units Affected
29 kits
Distribution
IN, NC, MN, TX Foreign: Belgium, China, Germany, Jordan, Italy, Netherlands, Malaysia, Spain, Thailand
Location
Germantown, MD

Frequently Asked Questions

What product was recalled?
therascreen FGFR RGQ RT-PCR Kit (CE IVD, not sold in the US) REF 874711. Recalled by Qiagen Sciences LLC. Units affected: 29 kits.
Why was this product recalled?
Increased occurrence rate of false positive results, lead to a false positive sample result that could subsequently be incorrectly reported from the laboratory. A false positive result could lead to the risk of the patient being exposed to an inappropriate or suboptimal anti-cancer treatment and/or unnecessarily experiencing side effects
Which agency issued this recall?
This recall was issued by the FDA Devices on September 7, 2022. Severity: Moderate. Recall number: Z-1651-2022.